Jayson Bedford
Stock Analyst at Raymond James
Total Price Targets
23
Stocks Covered
15
Sectors
Financial Services, Healthcare
Most Recent
Feb 23, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Jayson Bedford
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| AXGN | AxoGen, Inc. | $41.00 | $43.42 | -5.6% | 2 | Feb 23, 2026 |
| EW | Edwards Lifesciences Corporation | $96.00 | $84.24 | +14.0% | 1 | Nov 3, 2025 |
| BSX | Boston Scientific Corporation | $121.00 | $56.91 | +112.6% | 1 | Jul 21, 2025 |
| JNJ | Johnson & Johnson | $162.00 | $227.97 | -28.9% | 4 | Apr 14, 2025 |
| MASI | Masimo Corporation | $170.00 | $178.56 | -4.8% | 1 | Nov 6, 2024 |
| PODD | Insulet Corporation | $260.00 | $175.12 | +48.5% | 2 | Oct 14, 2024 |
| ZBH | Zimmer Biomet Holdings, Inc. | $128.00 | $83.24 | +53.8% | 1 | Aug 8, 2024 |
| BDX | Becton, Dickinson and Company | $212.26 | $149.07 | +42.4% | 1 | Aug 2, 2024 |
| ABT | Abbott Laboratories | $127.00 | $89.76 | +41.5% | 3 | Jul 18, 2024 |
| ICUI | ICU Medical, Inc. | $135.00 | $118.65 | +13.8% | 1 | Jun 17, 2024 |
| ISRG | Intuitive Surgical, Inc. | $310.00 | $459.71 | -32.6% | 2 | Oct 20, 2023 |
| KMPR | Kemper Corporation | $128.00 | $34.17 | +274.5% | 1 | Oct 6, 2023 |
| TNDM | Tandem Diabetes Care, Inc. | $92.00 | $19.34 | +375.7% | 1 | Aug 17, 2022 |
| MDT | Medtronic plc | $116.00 | $80.42 | +44.2% | 1 | Feb 18, 2022 |
| DXCM | DexCom, Inc. | $33.63 | $61.51 | -45.3% | 1 | Jan 19, 2022 |
Recent Activity
- Feb 23, 2026— Set$41.00price target onAXGN(AxoGen, Inc.)
- Dec 4, 2025— Set$36.00price target onAXGN(AxoGen, Inc.)
- Nov 3, 2025— Set$96.00price target onEW(Edwards Lifesciences Corporation)
- Jul 21, 2025— Set$121.00price target onBSX(Boston Scientific Corporation)
- Apr 14, 2025— Set$162.00price target onJNJ(Johnson & Johnson)
- Nov 6, 2024— Set$170.00price target onMASI(Masimo Corporation)
- Oct 14, 2024— Set$260.00price target onPODD(Insulet Corporation)
- Aug 8, 2024— Set$128.00price target onZBH(Zimmer Biomet Holdings, Inc.)
- Aug 2, 2024— Set$212.26price target onBDX(Becton, Dickinson and Company)
- Jul 18, 2024— Set$127.00price target onABT(Abbott Laboratories)
- Jun 17, 2024— Set$135.00price target onICUI(ICU Medical, Inc.)
- Mar 27, 2024— Set$175.00price target onJNJ(Johnson & Johnson)
- Dec 28, 2023— Set$110.00price target onJNJ(Johnson & Johnson)
- Oct 20, 2023— Set$310.00price target onISRG(Intuitive Surgical, Inc.)
- Oct 6, 2023— Set$128.00price target onKMPR(Kemper Corporation)
- Aug 23, 2022— Set$280.00price target onPODD(Insulet Corporation)
- Aug 17, 2022— Set$92.00price target onTNDM(Tandem Diabetes Care, Inc.)
- Apr 25, 2022— Set$135.00price target onABT(Abbott Laboratories)
- Apr 18, 2022— Set$195.00price target onJNJ(Johnson & Johnson)
- Feb 18, 2022— Set$116.00price target onMDT(Medtronic plc)
Frequently Asked Questions
Who is Jayson Bedford?
Jayson Bedford is a stock analyst at Raymond James covering 15 stocks primarily in Financial Services, Healthcare. They have issued 23 price targets since Jan 19, 2022.
What stocks does Jayson Bedford cover?
Jayson Bedford currently covers 15 stocks, including JNJ, ABT, AXGN, PODD, ISRG.
What is Jayson Bedford's latest price target?
Jayson Bedford's most recent price target was $41.00 on AXGN (AxoGen, Inc.), set on Feb 23, 2026.
What is Jayson Bedford's highest price target?
Jayson Bedford's highest issued price target is $334.00 on ISRG, set on Jan 21, 2022.
More Analysts at Raymond James
Coverage based on publicly published price targets. Not investment advice.